Trump's bad habit of overpromising and underdelivering

Why the president's claims about convalescent plasma should be met with skepticism

President Trump.
(Image credit: Illustrated | Getty Images, iStock)

President Trump keeps making a rookie political mistake: overpromising and underdelivering. He did it again Sunday, making the "truly history announcement" that the Food and Drug Administration had given emergency use authorization to allow doctors to treat COVID-19 patients with convalescent plasma — basically, an infusion from patients who have recovered from the virus.

Convalescent plasma is a "powerful therapy," Trump said. "It has an incredible rate of success."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Joel Mathis, The Week US

Joel Mathis is a writer with 30 years of newspaper and online journalism experience. His work also regularly appears in National Geographic and The Kansas City Star. His awards include best online commentary at the Online News Association and (twice) at the City and Regional Magazine Association.